Novo Nordisk may attempt to mitigate the impact from off-patent competition by protecting their share of Wegovy by enhancing weight-management services, or migrating patients from semaglutide to newer, patent-protected AOMs, including offering an oral version of semaglutide, effectively offering therapies with greater patient benefits
The most commonly reported side effects for both agents are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
J Neurol Sci 235(1-2):6168 Knippenberg S, Thau N, Schwabe K, Dengler R, Schambach A, Hass R, Petri S (2012) Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis
GLP-1 medications slow gastric emptying and reduce appetite, which means you're eating less overall
The injection volumes remain small, which many researchers prefer for subcutaneous administration
Step 2: Pay and schedule your video consultation